NEW COMBINATION THERAPIES FOR TREATING NERVOUS SYSTEM DISEASES

摘要

The invention is directed to combinations of alitretinoin and pranlukast or to combinations of alitretinoin and mefloquine, to pharmaceutical compositions, kits and treatment methods for the treatment or prevention of nervous system disorders, particularly motor neuron disease, spinal cord disease and/or nervous system disease associated with glutamate excitotoxicity, including amyotrophic lateral sclerosis.